Literature DB >> 27300259

AKT Signaling Prevailing in Mesenchymal Stromal Cells Modulates the Functionality of Hematopoietic Stem Cells via Intercellular Communication.

Shweta Singh1, Ranjita Devi Moirangthem1, Anuradha Vaidya1,2, Sapana Jalnapurkar1, Lalita Limaye1, Vaijayanti Kale3.   

Abstract

The AKT pathway plays an important role in various aspects of stem cell biology. However, the consequences of constitutive activation of AKT in mesenchymal stromal cells (MSCs) on the fate of hematopoietic stem cells (HSCs) were unknown. Here, we show that bone marrow-derived MSCs expressing a constitutively active AKT1 expand HSCs, but severely affect their functionality. Conversely, stromal cells with silenced AKT1 limit HSC proliferation, but boost their functionality. These effects were related to differential modulation of several important regulatory genes, in both, the cocultured HSCs and in the stromal cells themselves. The detrimental effect of stromal cells with constitutively activated AKT1 involved dynamin-dependent endocytosis, whereas the salutary effect of stromal cells devoid of AKT1 was mediated via GAP junctions. Constitutive activation of AKT1 led to deregulated formation of GAP junctions in the stromal cells, which consequently exhibited strikingly increased intercellular transfer of molecular cargo to the HSCs. Conversely, stromal cells with silenced AKT1 exhibited normal intercellular arrangement of GAP junctions at appositional membrane areas, and did not show aberrant intercellular transfer. Micro-vesicles isolated from conditioned media of the stromal cells not only mimicked the effect of these cells, but also showed stronger effects. This is perhaps the first report demonstrating that AKT1 signaling prevailing in the MSCs regulates HSC functionality through various intercellular communication mechanisms. These findings could have important implications in the use of MSCs in regenerative medicine. Stem Cells 2016;34:2354-2367.
© 2016 AlphaMed Press.

Entities:  

Keywords:  AKT1; CXCR4; Endocytosis; GAP junctions; Hematopoietic stem cells; Intercellular communication; Mesenchymal stromal cells

Mesh:

Substances:

Year:  2016        PMID: 27300259     DOI: 10.1002/stem.2409

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  The Intercellular Communication Between Mesenchymal Stromal Cells and Hematopoietic Stem Cells Critically Depends on NF-κB Signalling in the Mesenchymal Stromal Cells.

Authors:  Shalmali Pendse; Vaijayanti Kale; Anuradha Vaidya
Journal:  Stem Cell Rev Rep       Date:  2022-03-26       Impact factor: 6.692

Review 2.  Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.

Authors:  Edward Allan Racela Sison; Peter Kurre; Yong-Mi Kim
Journal:  Pediatr Hematol Oncol       Date:  2017-12-06       Impact factor: 1.969

3.  Pharmacological Inhibition of p38 MAPK Rejuvenates Bone Marrow Derived-Mesenchymal Stromal Cells and Boosts their Hematopoietic Stem Cell-Supportive Ability.

Authors:  Pallavi Budgude; Vaijayanti Kale; Anuradha Vaidya
Journal:  Stem Cell Rev Rep       Date:  2021-08-22       Impact factor: 5.739

Review 4.  Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk.

Authors:  Kelly L Harris; Meagan B Myers; Karen L McKim; Rosalie K Elespuru; Barbara L Parsons
Journal:  Environ Mol Mutagen       Date:  2019-10-06       Impact factor: 3.216

5.  Oestrogen retains human periodontal ligament stem cells stemness in long-term culture.

Authors:  Qianmin Ou; Xiaoxiao Wang; Yanlan Wang; Yan Wang; Xuefeng Lin
Journal:  Cell Prolif       Date:  2017-10-12       Impact factor: 6.831

6.  Recombinant Klotho Protects Human Periodontal Ligament Stem Cells by Regulating Mitochondrial Function and the Antioxidant System during H2O2-Induced Oxidative Stress.

Authors:  Huan Chen; Xiaojun Huang; Chuanqiang Fu; Xiayi Wu; Yingying Peng; Xuefeng Lin; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2019-11-28       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.